487 related articles for article (PubMed ID: 24656178)
1. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
Scheffer HJ; Nielsen K; de Jong MC; van Tilborg AA; Vieveen JM; Bouwman AR; Meijer S; van Kuijk C; van den Tol PM; Meijerink MR
J Vasc Interv Radiol; 2014 Jul; 25(7):997-1011; quiz 1011. PubMed ID: 24656178
[TBL] [Abstract][Full Text] [Related]
2. Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.
Savic LJ; Chapiro J; Hamm B; Gebauer B; Collettini F
Rofo; 2016 Aug; 188(8):735-45. PubMed ID: 27074423
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system.
Hosein PJ; Echenique A; Loaiza-Bonilla A; Froud T; Barbery K; Rocha Lima CM; Yrizarry JM; Narayanan G
J Vasc Interv Radiol; 2014 Aug; 25(8):1233-1239.e2. PubMed ID: 24861662
[TBL] [Abstract][Full Text] [Related]
4. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
Simmerman E; Chung J; Lawson A; Kruse E
J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
[TBL] [Abstract][Full Text] [Related]
5. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
[TBL] [Abstract][Full Text] [Related]
6. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
[TBL] [Abstract][Full Text] [Related]
7. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
[TBL] [Abstract][Full Text] [Related]
8. Irreversible Electroporation for Colorectal Liver Metastases.
Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
[TBL] [Abstract][Full Text] [Related]
9. Anaesthetic management during open and percutaneous irreversible electroporation.
Nielsen K; Scheffer HJ; Vieveen JM; van Tilborg AA; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR; Bouwman RA
Br J Anaesth; 2014 Dec; 113(6):985-92. PubMed ID: 25173767
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
[TBL] [Abstract][Full Text] [Related]
11. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
12. Introduction to Irreversible Electroporation--Principles and Techniques.
Thomson KR; Kavnoudias H; Neal RE
Tech Vasc Interv Radiol; 2015 Sep; 18(3):128-34. PubMed ID: 26365541
[TBL] [Abstract][Full Text] [Related]
13. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
[TBL] [Abstract][Full Text] [Related]
14. Irreversible Electroporation of Hepatic and Pancreatic Malignancies: Radiologic-Pathologic Correlation.
Gonzalez-Beicos A; Venkat S; Songrug T; Poveda J; Garcia-Buitrago M; Poozhikunnath Mohan P; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):176-82. PubMed ID: 26365548
[TBL] [Abstract][Full Text] [Related]
15. Niche Applications of Irreversible Electroporation.
Bhatia SS; Arya R; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):170-5. PubMed ID: 26365547
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation for the ablation of liver tumors: are we there yet?
Charpentier KP
Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P
Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study.
Buijs M; Zondervan PJ; de Bruin DM; van Lienden KP; Bex A; van Delden OM
Urol Oncol; 2019 Mar; 37(3):183.e1-183.e8. PubMed ID: 30509869
[TBL] [Abstract][Full Text] [Related]
19. Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y
J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820
[TBL] [Abstract][Full Text] [Related]
20. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
Dollinger M; Jung EM; Beyer L; Niessen C; Scheer F; Müller-Wille R; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Oct; 25(10):1589-94. PubMed ID: 25156648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
